Pathology/Lab Coding Alert

Reader Question:

Remember CLIA Status Modifier

Question: We're a CLIA-waived lab performing the NMP22 test by Alere. How should we report the test? Tennessee Subscriber Answer: The new CPT® 2012 code for nuclear matrix protein 22 (NMP22) is 86386 (Nuclear Matrix Protein 22 [NMP22], qualitative), but that's not the entire answer to your question. Because you're a lab operating with waived status under the Clinical Laboratory Improvement Amendments (CLIA), you can only perform and report tests that are granted waived status. When you report a waived test, you need to append modifier QW (CLIA waived test). You'll find that the latest quarterly CLIA-waived test list includes 86386-QW, along with the 12 other tests. According to Transmittal 2408 dated Feb. 3, CMS will now consider the following tests CLIA-waived, among others: 81003 (Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Pathology/Lab Coding Alert

View All